Referral to emergency

If any of the following are present or suspected, please refer the patient to the emergency department (via ambulance if necessary) or seek emergent medical advice if in a remote region.

  • complications of disease or therapy requiring emergent review – systemically unwell

Please contact the on-call registrar to discuss your concerns prior to referral.

For clinical advice, please telephone the relevant metropolitan Local Health Network switchboard and ask to speak to the relevant specialty service.

Central Adelaide Local Health Network

Northern Adelaide Local Health Network

Southern Adelaide Local Health Network

Category 1 (appointment clinically indicated within 30 days)

  • new onset and/or active myositis including polymyositis, dermatomyositis, connective tissue disease associated myositis and undifferentiated inflammatory myositis

Category 2 (appointment clinically indicated within 90 days)

  • inflammatory myositis on established treatment and stable
  • possible myositis with weakness for further review

Category 3 (appointment clinically indicated within 365 days)

  • nil

For information on referral forms and how to import them, please view general referral information.

Essential referral information

Completion required before first appointment to ensure patients are ready for care. Please indicate in the referral if the patient is unable to access mandatory tests or investigations as they incur a cost or are unavailable locally.

  • identifies as Aboriginal and/or Torres Strait Islander
  • relevant social history, including identifying if you feel your patient is from a vulnerable population and/or requires a third party to receive correspondence on their behalf
  • interpreter required
  • if the patient is pregnant or planning a pregnancy
  • complete medical history
  • details of previous medical management including the course of treatment and outcome
  • current and previous medication history including statins, non-prescription medicines, herbs and supplements, the course of treatment and outcome of treatment
  • history of presenting condition:
    • description of joints affected and characteristics
    • duration of symptoms for < 6 weeks, > 6 weeks, >12 months, > 2 years
    • symptoms including weakness and /or pain, extent of skin, joint, respiratory or other symptoms
  • clinical examination:
    • proximal and/or distal muscle weakness
    • swollen joints
    • skin changes
  • blood results including location of company and accession number if available:
    • full blood count (FBC)
    • electrolytes, urea, creatinine (EUC)
    • estimated glomerular filtration rate (eGFR)
    • liver function tests (LFTs)
    • C-reactive protein (CRP)
    • creatinine kinase
    • thyroid function test
    • antinuclear antibody (ANA) titre and pattern must be included, if ANA is positive, extractable nuclear antigen (ENA) and dsDNA including myositis antibodies if available
    • complement levels (C3, C4)

Additional information to assist triage categorisation

  • family history of autoimmune disease
  • relevant allied health/diagnostic/imaging reports including location of company and accession number
  • previous assessments or opinions from a rheumatologist or other relevant specialist or allied health clinician
  • interference with activities of daily living and working ability - for example, has the patient had to stop or change work practices, are they requiring assistance with self care
  • muscle or skin biopsy histology